Literature DB >> 9846849

Effect of apolipoprotein E polymorphism on serum lipid response to the separate modification of dietary fat and dietary cholesterol.

E Sarkkinen1, M Korhonen, A Erkkilä, T Ebeling, M Uusitupa.   

Abstract

BACKGROUND: The magnitude of the influence of the apolipoprotein (apo) E genotype on the lipid response to different cholesterol-lowering diet modifications has been controversial.
OBJECTIVE: The aim of the study was to investigate the effect of apo E genotype on serum lipid response to the separate modification of dietary fat and cholesterol.
DESIGN: A prospective study design with the 3 main apo E genotype groups (3/3, 3/4, and 4/4; n = 15 in each group) was used. Groups were matched for sex, age, body mass index, menopausal status, and baseline serum cholesterol concentration. Subjects followed 3 different diets in fixed order: 1) a standardized baseline diet (38% fat, 300 mg cholesterol/d), 2) a modified National Cholesterol Education Program (NCEP) diet (34% fat, 265 mg cholesterol/d), and 3) the modified NCEP diet + cholesterol (566 mg cholesterol/d). Subjects were middle-aged (50.9 +/- 8.0 y) and mildly hypercholesterolemic (6.55 +/- 1.05 mmol/L).
RESULTS: The genotype groups differed in their total cholesterol response to the NCEP diet; the mean (95% CI) decrease being greatest, -14.1% (-19.8%, -8.6% ), in subjects with apo E genotype 4/4 (P = 0.03, analysis of variance). The increase in total cholesterol after addition of 300 mg cholesterol was also greatest in subjects with apo E 4/4 [10.4% (5.8%, 15.1%)] (P = 0.03, analysis of variance).
CONCLUSIONS: Apo E genotype modified the lipid response to changes in both dietary fat and cholesterol in mildly hypercholesterolemic subjects; the response was greatest in subjects with apo E genotype 4/4 and even a moderate increase in dietary cholesterol resulted in a 10% elevation in serum total cholesterol in them.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846849     DOI: 10.1093/ajcn/68.6.1215

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  16 in total

1.  The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank.

Authors:  G D Tan; M J Neville; E Liverani; S M Humphreys; J M Currie; L Dennis; B A Fielding; F Karpe
Journal:  Diabetologia       Date:  2005-12-17       Impact factor: 10.122

2.  Role of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia.

Authors:  Valerie Leduc; Lucienne Bourque; Judes Poirier; Robert Dufour
Journal:  Pharmacogenet Genomics       Date:  2016-01       Impact factor: 2.089

3.  A short-term religious "fast" from animal products has a minimal impact on cardiometabolic health biomarkers irrespective of concurrent shifts in distinct plant-based food groups.

Authors:  Hilary J Bethancourt; Mario Kratz; Kathleen O'Connor
Journal:  Am J Clin Nutr       Date:  2019-09-01       Impact factor: 7.045

Review 4.  Revisiting Human Cholesterol Synthesis and Absorption: The Reciprocity Paradigm and its Key Regulators.

Authors:  Peter A S Alphonse; Peter J H Jones
Journal:  Lipids       Date:  2015-11-30       Impact factor: 1.880

Review 5.  Influence of dietary saturated fatty acids on the regulation of plasma cholesterol concentration.

Authors:  Michaelann S Wilke; M Thomas Clandinin
Journal:  Lipids       Date:  2005-12       Impact factor: 1.880

6.  Genetic variation of apolipoprotein E does not contribute to the lipid abnormalities secondary to childhood minimal change nephrotic syndrome.

Authors:  Peng Hu; Yuan Han Qin; Ling Lu; Bo Hu; Cheng Xue Jing; Feng Ying Lei; Ming Fang Li
Journal:  Int Urol Nephrol       Date:  2009-02-25       Impact factor: 2.370

7.  Effects of apolipoprotein E genotype on blood cholesterol in adolescent girls.

Authors:  Janet E Fulton; Shifan Dai; Jo Anne Grunbaum; Eric Boerwinkle; Darwin R Labarthe
Journal:  Am J Prev Med       Date:  2009-07       Impact factor: 5.043

8.  Treatment of dyslipidemia: genetic interactions with diet and drug therapy.

Authors:  J M Ordovas; E J Schaefer
Journal:  Curr Atheroscler Rep       Date:  1999-07       Impact factor: 5.967

9.  Function and comorbidities of apolipoprotein e in Alzheimer's disease.

Authors:  Valérie Leduc; Dorothée Domenger; Louis De Beaumont; Daphnée Lalonde; Stéphanie Bélanger-Jasmin; Judes Poirier
Journal:  Int J Alzheimers Dis       Date:  2011-04-05

10.  Associations between apolipoprotein E genotype, diet, body mass index, and serum lipids in Lithuanian adult population.

Authors:  Janina Petkeviciene; Alina Smalinskiene; Dalia Ieva Luksiene; Kristina Jureniene; Vitalija Ramazauskiene; Jurate Klumbiene; Vaiva Lesauskaite
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.